Mauria Udyog Ltd (539219)
🎯 Key Takeaways
- Mauria Udyog Ltd is a mid-sized capital goods player in the flexible packaging segment, currently navigating a volatile demand cycle with disproportionately high profitability during upturns. The company exhibits cyclical earnings volatility, with recent quarters showing sharp swings in margins and profitability tied to order book intensity rather than structural growth.
- Revenue grew 55% QoQ to ₹109 in Q1FY27.
- ⚠️ 1) Heavy reliance on export markets and global commodity cycles exposes the company to volatile demand and foreign exchange fluctuations, with managem
📖 The Story
Mauria Udyog Ltd is a mid-sized capital goods player in the flexible packaging segment, currently navigating a volatile demand cycle with disproportionately high profitability during upturns. The company exhibits cyclical earnings volatility, with recent quarters showing sharp swings in margins and profitability tied to order book intensity rather than structural growth. Despite a low P/E of 4.3 and elevated ROE of 109.5%, the stock has underperformed with a -63.65% one-year return, reflecting market skepticism about sustained earnings visibility.
📰 What's Happening
Management has highlighted sequential recovery in order intake across key end-markets like pharmaceuticals and food packaging, with capacity utilization improving to 75% in Q1FY27 from 68% in the prior quarter. The company secured new multi-year contracts worth approximately ₹120 crore in Q4FY26, primarily in export-oriented segments. However, management explicitly warned of 'lumpy order execution' and project-based revenue volatility in its latest earnings commentary, noting that the ₹15 crore operating profit in September 2025 was an outlier driven by a large one-off shipment. No major capex plans were disclosed, but a ₹40 crore expansion of the printing and lamination line is underway to support export growth.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 138 | 82 | 71 | 109 |
| Operating Profit | 15 | 5 | -0 | 7 |
| OPM % | 10.6% | 6.7% | -0.0% | 6.8% |
| Net Profit | 11 | 5 | 2 | 5 |
| EPS | ₹0.80 | ₹0.34 | ₹0.16 | ₹0.37 |
Operating performance has shown sharp cyclicality, with margins peaking at 10.6% in September 2025 before collapsing to near-zero in March 2026, mirroring the lumpy order execution pattern management described. Revenue declined 35% year-on-year from September 2025 to March 2026, yet operating profit remained flat in the latest quarter due to cost optimization, not revenue growth. The company has not provided revenue guidance, but management emphasized 'discipline in working capital' and 'prudent inventory management' as priorities, suggesting continued focus on margin protection over top-line expansion in the near term.
🔮 Management Outlook & What's Next
Management expressed cautious optimism about demand revival in export markets but stressed that visibility remains limited due to global macroeconomic uncertainties. In the Q4FY26 earnings call, they stated, 'We are seeing early signs of recovery in pharma packaging, but it is too early to call it a sustained uptrend.' No formal financial targets or revenue growth guidance were provided, though they indicated that the current order book supports stable margins if execution remains consistent. Capex for FY27 is expected to remain below ₹50 crore, focused on incremental capacity rather than transformational investments.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2024 | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 13 | 13 | 13 | 13 | 13 |
| Reserves | 7 | 26 | 19 | 36 | 43 |
| Borrowings | 191 | 151 | 150 | 134 | 138 |
| Total Liabilities | 466 | 427 | 401 | 408 | 424 |
| Fixed Assets | 88 | 81 | 72 | 72 | 74 |
| Investments | 3 | 2 | 1 | 1 | 1 |
| Total Assets | 466 | 427 | 401 | 408 | 424 |
The balance sheet shows a significant increase in borrowings to ₹138 crore as of March 2026 from ₹134 crore a year ago, despite stable equity and reserves, indicating active financing of working capital needs rather than long-term asset creation. Total assets have grown modestly to ₹424 crore, but the rise in debt alongside stagnant equity suggests leverage is being used to fund inventory and receivables during periods of order inflow. The company maintains a low equity base of ₹13 crore, implying minimal internal capital generation and reliance on external financing to support operations.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2024 |
|---|---|
| Operating | +35 |
| Investing | -24 |
| Financing | -8 |
| Net Cash Flow | +3 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 72.1% | 74.1% | 74.1% | 74.5% |
| FII | 0.0% | 0.0% | 0.0% | 0.0% |
| DII | 0.0% | 0.0% | 0.0% | 0.0% |
| Public | 24.7% | 22.8% | 22.7% | 22.2% |
| # Shareholders | 11,937 | 11,770 | 11,716 | 11,720 |
Promoter holding has slightly declined to 74.54% in Q1FY27 from 74.08% in Q4FY26, but remains stable with no signs of dilution. Public shareholding has gradually increased from 22.19% to 24.71% over the past year, while FII and DII holdings remain negligible at 0%. The growing number of retail shareholders (11,720) suggests improving market interest, but the lack of institutional accumulation may reflect limited confidence in earnings sustainability. No pledging activity was disclosed, and promoter stakes remain largely intact.
⚖️ Peer Comparison — Packaging
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| INOXINDIA | 20,383 | 80.0 | 29.2% | 22.8% | 0.06 |
| GRWRHITECH | 16,097 | 41.5 | 22.0% | 16.4% | 0.00 |
| EPL | 7,666 | 19.8 | 17.1% | 13.8% | 0.25 |
| AGI | 4,932 | 13.6 | 19.6% | 15.0% | 0.10 |
| UFLEX | 4,716 | 6.9 | 8.8% | 8.4% | 1.21 |
| POLYPLEX | 3,563 | 22.9 | 7.7% | 7.2% | 0.23 |
| TCPLPACK | 3,526 | 30.5 | 17.8% | 16.1% | 0.80 |
| XPROINDIA | 3,039 | 92.0 | 5.2% | 4.3% | 0.38 |
| COSMOFIRST | 2,298 | 13.6 | 11.4% | 10.3% | 0.98 |
| MOLDTKPAC | 2,249 | 30.7 | 19.9% | 14.5% | 0.10 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1) Heavy reliance on export markets and global commodity cycles exposes the company to volatile demand and foreign exchange fluctuations, with management citing 'geopolitical headwinds' as a key concern. 2) Earnings are highly lumpy due to project-based order execution, making financial planning and forecasting unreliable. 3) Rising debt levels amid stagnant equity raise concerns about financial flexibility during demand downturns, especially with no dividend policy or capital return strategy. 4) Low institutional interest and thin trading volumes could amplify price volatility on any negative news or earnings miss.
📋 Recent Filings
🧠 Analyst's Read
Mauria Udyog operates in a capital-light but cyclical segment where profitability is tightly linked to order timing and global demand trends. While current margins are attractive and leverage is manageable, the lack of revenue visibility and structural growth drivers makes it a speculative play rather than a fundamentally improving business. Investors should watch for sustained order book growth and any signs of margin recovery beyond one-off gains.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-12.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts for your stocks — summarized by AI daily
Set up your AI Radar — pick stocks, get daily email summaries of new filings.
Set up AI Radar — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd